Skip to content

Hypophosphatemia Deleteriously Affects Outcome of Septic Shock Patients Admitted to ICU

Hypophosphatemia Deleteriously Affects Outcome of Septic Shock Patients Admitted to ICU

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04455113
Enrollment
317
Registered
2020-07-02
Start date
2018-06-01
Completion date
2020-06-01
Last updated
2020-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of Hypophosphatemia on Septic Patients

Brief summary

Patients with severe sepsis/septic shock complicated by hypophosphatemia are at high risk of developing morbidities other than that underlying sepsis and more vulnerable to higher mortality rate. Thus, the current study hypothesized that diagnosis and management of hypophosphatemia may be advantageous for reduction of morbidity and mortality rates of septic patients admitted to ICU

Detailed description

The current study was started since June 2018 till Jan 2020 after approval of the study protocol by the Local Ethical Committee. The study intended to include all patients admitted to ICU with or developed severe sepsis or septic shock within 24-hr after admission to ICU. All patients admitted to ICU were eligible to evaluation for demographic and clinical data including hemodynamic data. Disease severity and its impact on body organs were evaluated using acute physiology and chronic health evaluation II score (APACHE II) (20) and SOFA (18) scores. Exclusion criteria included maintenance on immunodepressent therapy for any indication, severe hemorrhagic shock, pregnancy and refusal of nearest relative to sign the written concept for study participation. Children and adulthoods younger than 18 years and patients who were expected to die were also excluded from the study.

Interventions

DIAGNOSTIC_TESTPhosphorus level

infusion

Sponsors

Ayman Anis Metry
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* All patients admitted to ICU were eligible to evaluation for demographic and clinical data including hemodynamic data. * Disease severity and its impact on body organs were evaluated using acute physiology and chronic health evaluation II score (APACHE II) (20) and SOFA (18) scores.

Exclusion criteria

* Maintenance on immunodepressent therapy. * Severe hemorrhagic shock. * Pregnancy * Refusal of nearest relative to sign the written concept for study participation.

Design outcomes

Primary

MeasureTime frame
The 28-day ICU mortality rate (28-MR)28 days

Secondary

MeasureTime frame
The incidence of additional morbidities.30 days
The correlation between 28-MR and incidence of additional morbidities and severity of HP.28 days

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026